Stem Cell Advisor

This article explores leading stem cell centers within the U.S. and worldwide.  The global regenerative medicine market size is calculated at USD 20.09 billion in 2024 and is expected to be worth USD 139.70 billion by 2034, expanding at a CAGR of 21.4% from 2024 to 2034, as a result of the rising demand for cell and gene therapies. ( source ) The global stem cell therapy market size (sub-set of regenerative medicine) was exhibited at USD 14.15 billion in 2023 and is projected to hit around USD 49.11 billion by 2033, growing at a CAGR of 13.25% during the forecast period 2024 to 2033. ( Nova1Advisor ) Below, we cover leading stem cell centers. Each one has treated large populations of patients with adult stem cells. At least one (Regenexx) is maintaining a Patient Registry to document long-term patient outcomes. Others, like GIOSTAR, have been working with the U.S. FDA on clinical trials related to the treatment of COVID-1...

Abstract   Regenerative medicine represents a transformative frontier in healthcare, offering solutions for diseases and conditions previously deemed untreatable. In Malaysia, the field has gained traction, propelled by advancements in stem cell therapy, tissue engineering, and biomaterials. This paper reviews the current state of regenerative medicine in Malaysia, highlighting achievements, ongoing research, and regulatory frameworks. Key challenges, including ethical concerns, funding limitations, and public awareness, are critically examined. Additionally, strategic recommendations are proposed to foster innovation and establish Malaysia as a regional hub for regenerative medicine. 1. Introduction   Regenerative medicine encompasses a multidisciplinary approach to repair, replace, or regenerate damaged tissues and organs. With its potential to address conditions such as diabetes, cardiovascular diseases, and degenerative disorders, regenerative medicine has emerged as a cri...

What are Natural Killer Cells? Natural killer (NK) cells, a specific type of white blood cell, are an important component of your innate immune system. Your immune system consists of two different branches — cell-mediated immunity (innate) and humoral immunity (adaptive). When you contract a viral disease, the pathogen enters your body and infects your cells. NK Cell Therapy Market Size The global natural killer cells therapeutics market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027 ( R ). Analysis by Data Bridge Market Research reported that the Natural Killer (NK) Cell Therapeutics Market will grow at a CAGR (compound annual growth rate) of 40.9% during the forecast by 2029. NK cell for cancer immunotherapy Benefits and Side Effects of Transfusing NK Cells In terms of benefits, NK cells are the hardest to produce in the body, so transfusing a large amount automatically strengthens the patient’s immune sy...

One of the most promising approaches in cellular therapies is immunotherapies using engineered T cells or natural killer (NK) cells expressing chimeric antigen receptors (CARs). Will CAR-NK cell therapies overshadow traditional CAR-T options for the treatment of some cancers? As of June 2024,  more than 50 studies  have been launched to investigate the potential of CAR-NK cell therapy. While CAR T-cell therapy is more well-known and studied, there are challenges to the manufacturing of CAR T that does not exist with CAR-NK. This may prove to be a game-changer for blood cancer patients who do not have the time to wait for a CAR T-cell donor or for their own cells to be engineered for treatment. Researchers have tried to modify natural killer (NK) cells with chimeric antigen receptors (CAR) to increase potential to bind and destroy cancer cells, known as NK cell therapy. Here we describe the differences between CAR T ce...